IP Library Granted Patent US 8,882,653
Granted Patent B2
US 8,882,653 · App. 14/062,831 · Granted Nov 11, 2014

Methods and systems for performing a medical procedure

Inventors: John Gillespie, Jr. (Dover, MA); Ryan J. Cahill (Newton, MA); Kevin G. Connors (Wellesley, MA); Peter Dayton (Brookline, MA); Carla Wiese (Cambridge, MA)
Assignee: AttenueX Technologies, Inc.
A61B17/3468A61F2/0027A61F2/004A61B1/00068A61B1/12A61B1/307A61F2/042A61M1/0064A61M25/10A61M25/1002A61B17/295A61B5/205A61M39/22A61M39/223A61M39/28A61B2017/00805A61M2025/1054A61M2039/0009A61B2017/2926A61M25/007A61M25/0074A61B2017/345A61M2025/0681A61M2210/1078
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,882,653
App. No.
14/062,831
Granted
Nov 11, 2014
Kind
B2
Abstract

Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.

Claims (27)

1. A medical device, the medical device comprising an implantable inflatable cell having a cell wall and a valve, the valve configured to allow or prevent access to an interior of the inflatable cell defined by the cell wall to inflate or deflate the cell and to allow the inflatable cell to be implanted within a body in a deflated state to then be inflated to an inflated state;

wherein the interior of the inflatable cell increases in volume by at least 10%, but less than 50% when internal pressure increases by 30 cmH2O from the cell volume at zero pressure; and

wherein the inflatable cell is made of polyurethane.

2. The medical device of claim 1 , wherein the inflatable cell increases in volume by at least 15% from the cell volume at zero pressure.

3. The medical device of claim 1 , wherein the inflatable cell has a wall thickness of between about 0.0001 and about 0.25 inches.

4. The medical device of claim 1 , wherein the inflatable cell has a wall thickness of between about 0.0003 and about 0.005 inches.

5. The medical device of claim 1 , wherein the inflatable cell has an initial volume between about 0.1 cc and about 500 cc.

6. The medical device of claim 1 , wherein the inflatable cell has an initial volume between about 1 cc and about 180 cc.

7. The medical device of claim 1 , further comprising an inflation media comprising a high vapor pressure media.

8. A medical device, the medical device comprising an implantable inflatable cell having a cell wall and a valve, the valve configured to allow or prevent access to an interior of the inflatable cell defined by the cell wall to inflate or deflate the cell and to allow the inflatable cell to be implanted within a body in a deflated state to then be inflated to an inflated state;

wherein the interior of the inflatable cell increases in volume by at least 6%, but less than 12% when internal pressure increases by 15 cmH2O from the cell volume at zero pressure, the inflatable cell having a wall thickness of between about 0.0003 and about 0.005 inches.

9. The medical device of claim 8 , wherein the inflatable cell increases in volume by at least 10% from the cell volume at zero pressure.

10. The medical device of claim 8 , wherein the inflatable cell has a wall thickness of between about 0.0009 and about 0.0015 inches.

11. The medical device of claim 8 , wherein the inflatable cell is made of polyurethane.

12. The medical device of claim 8 , wherein the inflatable cell has an initial volume between about 0.1 cc and about 500 cc.

13. The medical device of claim 8 , wherein the inflatable cell has an initial volume between about 1 cc and about 180 cc.

14. The medical device of claim 8 , further comprising an inflation media comprising a high vapor pressure media.

15. A medical device, the medical device comprising an implantable inflatable cell having a cell wall and a valve, the valve configured to allow or prevent access to an interior of the inflatable cell defined by the cell wall to inflate or deflate the cell and to allow the inflatable cell to be implanted within a body in a deflated state to then be inflated to an inflated state;

wherein the interior of the inflatable cell increases in volume by at least 15%, but less than 24% when internal pressure increases by 30 cmH2O from the cell volume at zero pressure.

16. The medical device of claim 15 , wherein the inflatable cell has a wall thickness of between about 0.0003 and about 0.005 inches.

17. The medical device of claim 15 , wherein the inflatable cell is made of polyurethane.

18. The medical device of claim 15 , wherein the inflatable cell has an initial volume between about 0.1 cc and about 500 cc.

19. The medical device of claim 15 , wherein the inflatable cell has an initial volume between about 1 cc and about 180 cc.

20. The medical device of claim 15 , further comprising an inflation media comprising a high vapor pressure media.

21. A method of treating a patient comprising delivering the inflatable cell of claim 8 into a bladder in the deflated state and while within the bladder, inflating the implantable inflatable cell through the valve to the inflated state.

22. A method of treating a patient comprising delivering the inflatable cell of claim 1 into a bladder in the deflated state and while within the bladder, inflating the implantable inflatable cell through the valve to the inflated state.

23. A method of treating a patient comprising delivering the inflatable cell of claim 15 into a bladder in the deflated state and while within the bladder, inflating the implantable inflatable cell through the valve to the inflated state.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2019
From: ATTENUEX TECHNOLOGIES, INC.
To: SOLACE THERAPEUTICS, INC.
Reel/Frame 049282/0097 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2017
From: CAHILL, RYAN J.; CONNORS, KEVIN G.; DAYTON, PETER; GILLESPIE, JOHN, JR.; CAIRA, SHEILA; WIESE, CARLA; DUNCAN, SCOTT; GRUBER, WILLIAM
To: ATTENUEX TECHNOLOGIES, INC.
Reel/Frame 041030/0494 →
Continuity (4)
Continuation 13843621 · Mar 15, 2013
Provisional Application 61682184 · Aug 10, 2012
Provisional Application 61769719 · Feb 26, 2013
Related Publication 20140046125A1 · Feb 13, 2014